These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2320 related items for PubMed ID: 17114079

  • 1. PET/CT: will it change the way that we use CT in cancer imaging?
    Hicks RJ, Ware RE, Lau EW.
    Cancer Imaging; 2006 Oct 31; 6(Spec No A):S52-62. PubMed ID: 17114079
    [Abstract] [Full Text] [Related]

  • 2. FDG-PET in colorectal cancer.
    de Geus-Oei LF, Ruers TJ, Punt CJ, Leer JW, Corstens FH, Oyen WJ.
    Cancer Imaging; 2006 Oct 31; 6(Spec No A):S71-81. PubMed ID: 17114081
    [Abstract] [Full Text] [Related]

  • 3. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.
    Brush J, Boyd K, Chappell F, Crawford F, Dozier M, Fenwick E, Glanville J, McIntosh H, Renehan A, Weller D, Dunlop M.
    Health Technol Assess; 2011 Sep 31; 15(35):1-192, iii-iv. PubMed ID: 21958472
    [Abstract] [Full Text] [Related]

  • 4. PET/CT imaging in gynecologic malignancies: a critical overview of its clinical impact and our retrospective single center analysis.
    Dalla Palma M, Gregianin M, Fiduccia P, Evangelista L, Cervino AR, Saladini G, Borgato L, Nicoletto MO, Zagonel V.
    Crit Rev Oncol Hematol; 2012 Jul 31; 83(1):84-98. PubMed ID: 22245509
    [Abstract] [Full Text] [Related]

  • 5. Improved long-term survival after resection of colorectal liver metastases following staging with FDG positron emission tomography.
    Abbadi RA, Sadat U, Jah A, Praseedom RK, Jamieson NV, Cheow HK, Whitley S, Ford HE, Wilson CB, Harper SJ, Huguet EL.
    J Surg Oncol; 2014 Sep 31; 110(3):313-9. PubMed ID: 24737685
    [Abstract] [Full Text] [Related]

  • 6. Controversies in the management of colorectal liver metastases: role of PET and PET/CT.
    Wiering B, Vogel WV, Ruers TJ, Oyen WJ.
    Dig Surg; 2008 Sep 31; 25(6):413-20. PubMed ID: 19212113
    [Abstract] [Full Text] [Related]

  • 7. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
    Cuellar SL, Carter BW, Macapinlac HA, Ajani JA, Komaki R, Welsh JW, Lee JH, Swisher SG, Correa AM, Erasmus JJ, Hofstetter WL.
    J Thorac Oncol; 2014 Aug 31; 9(8):1202-6. PubMed ID: 25157774
    [Abstract] [Full Text] [Related]

  • 8. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V, Delrue L, Kelles A, Van Damme N, Van Huysse J, Berrevoet F, De Vos M, Duyck P, Peeters M.
    Acta Gastroenterol Belg; 2007 Aug 31; 70(4):331-8. PubMed ID: 18330088
    [Abstract] [Full Text] [Related]

  • 9. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.
    Ann Surg; 2009 Dec 31; 250(6):957-63. PubMed ID: 19687736
    [Abstract] [Full Text] [Related]

  • 10. Use of a decision analysis model to assess the cost-effectiveness of 18F-FDG PET in the management of metachronous liver metastases of colorectal cancer.
    Lejeune C, Bismuth MJ, Conroy T, Zanni C, Bey P, Bedenne L, Faivre J, Arveux P, Guillemin F.
    J Nucl Med; 2005 Dec 31; 46(12):2020-8. PubMed ID: 16330566
    [Abstract] [Full Text] [Related]

  • 11. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings.
    Abdel-Nabi H, Doerr RJ, Lamonica DM, Cronin VR, Galantowicz PJ, Carbone GM, Spaulding MB.
    Radiology; 1998 Mar 31; 206(3):755-60. PubMed ID: 9494497
    [Abstract] [Full Text] [Related]

  • 12. Preoperative staging of colorectal cancer: CT vs. integrated FDG PET/CT.
    Shin SS, Jeong YY, Min JJ, Kim HR, Chung TW, Kang HK.
    Abdom Imaging; 2008 Mar 31; 33(3):270-7. PubMed ID: 17610107
    [Abstract] [Full Text] [Related]

  • 13. Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
    Yao J, Gan G, Farlow D, Laurence JM, Hollands M, Richardson A, Pleass HC, Lam VW.
    ANZ J Surg; 2012 Mar 31; 82(3):140-4. PubMed ID: 22510123
    [Abstract] [Full Text] [Related]

  • 14. Role of positron emission tomography in the (re-)staging of oesophageal cancer.
    Westerterp M, Van Westreenen HL, Sloof GW, Plukker JT, Van Lanschot JJ.
    Scand J Gastroenterol Suppl; 2006 Mar 31; (243):116-22. PubMed ID: 16782630
    [Abstract] [Full Text] [Related]

  • 15. Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI.
    Wong CY, Salem R, Raman S, Gates VL, Dworkin HJ.
    Eur J Nucl Med Mol Imaging; 2002 Jun 31; 29(6):815-20. PubMed ID: 12029557
    [Abstract] [Full Text] [Related]

  • 16. The role of positron emission tomography in the management of pancreatic cancer.
    Pakzad F, Groves AM, Ell PJ.
    Semin Nucl Med; 2006 Jul 31; 36(3):248-56. PubMed ID: 16762614
    [Abstract] [Full Text] [Related]

  • 17. [Combined FDG PET/CT imaging for restaging of colorectal cancer patients: impact of image fusion on staging accuracy].
    Strunk H, Bucerius J, Jaeger U, Joe A, Flacke S, Reinhardt M, Hortling N, Palmedo H.
    Rofo; 2005 Sep 31; 177(9):1235-41. PubMed ID: 16123869
    [Abstract] [Full Text] [Related]

  • 18. The value of FDG-PET/CT in the post-treatment evaluation of endometrial carcinoma: a comparison of PET/CT findings with conventional imaging and CA 125 as a tumour marker.
    Ozcan Kara P, Kara T, Kaya B, Kara Gedik G, Sari O.
    Rev Esp Med Nucl Imagen Mol; 2012 Sep 31; 31(5):257-60. PubMed ID: 23067527
    [Abstract] [Full Text] [Related]

  • 19. Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning.
    Viganò L, Lopci E, Costa G, Rodari M, Poretti D, Pedicini V, Solbiati L, Chiti A, Torzilli G.
    Ann Surg Oncol; 2017 Apr 31; 24(4):1029-1036. PubMed ID: 27807727
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 116.